Author

Khaled F. Al‐Massri

Observed names: Khaled Al-Massri, Khaled F Al-Massri, Khaled F. Al-Massri

Institution: University of Palestine

Observed institutions: Cairo University, University of Palestine

ORCID: 0009-0004-5700-0914

Observed ORCID: 0009-0004-5700-0914

OpenAlex ID: A5070241386

Pregabalin and lacosamide ameliorate paclitaxel-induced peripheral neuropathy via inhibition of JAK/STAT signaling pathway and Notch-1 receptor

2018 · Khaled F. Al-Massri, Lamiaa A. Ahmed, et al. · Neurochemistry International · 59

New Approaches for Enhancement of the Efficacy of Mesenchymal Stem Cell-Derived Exosomes in Cardiovascular Diseases

2022 · Lamiaa Ahmed, Khaled Al-Massri · Tissue Engineering and Regenerative Medicine · 53

Mesenchymal stem cells therapy enhances the efficacy of pregabalin and prevents its motor impairment in paclitaxel-induced neuropathy in rats: Role of Notch1 receptor and JAK/STAT signaling pathway

2018 · Khaled F. Al-Massri, Lamiaa A. Ahmed, et al. · Behavioural Brain Research · 41

Mesenchymal stem cells in chemotherapy‐induced peripheral neuropathy: A new challenging approach that requires further investigations

2019 · Khaled F. Al‐Massri, Lamiaa A. Ahmed, et al. · Journal of Tissue Engineering and Regenerative Medicine · 40

Gut Microbiota Modulation for Therapeutic Management of Various Diseases: A New Perspective Using Stem Cell Therapy

2022 · Lamiaa A. Ahmed, Khaled F. Al-Massri · Current Molecular Pharmacology · 24

Exploring the Role of Mesenchymal Stem Cell–Derived Exosomes in Diabetic and Chemotherapy-Induced Peripheral Neuropathy

2024 · Lamiaa A. Ahmed, Khaled F. Al-Massri · Molecular Neurobiology · 20

Directions for Enhancement of the Therapeutic Efficacy of Mesenchymal Stem Cells in Different Neurodegenerative and Cardiovascular Diseases: Current Status and Future Perspectives

2021 · Lamiaa A. Ahmed, Khaled F. Al-Massri · Current Stem Cell Research & Therapy · 15

Insights into the role of gut microbiota modulation in the management of various cardiovascular diseases: A new approach for improving the efficacy of current cardiovascular medications

2025 · Lamiaa A. Ahmed, Khaled F. Al-Massri · European Journal of Pharmacology · 3

Mesenchymal stem cells and their exosomes as novel modulators of gut microbiota: Therapeutic perspectives for liver diseases and inflammatory bowel disease

2026 · Khaled F. Al-Massri · Microbial Pathogenesis · 1

Potential Therapies Using Engineered Mesenchymal Stem Cell-Derived Exosomes in Gastrointestinal Diseases

2026 · Lamiaa A. Ahmed, Manar A. Didamoony, et al. · CRC Press eBooks

Impact of co-morbidities on preconditioning signalling cascades in cardiovascular diseases: strategies for intervention

2026 · Lamiaa A. Ahmed, Khaled F. Al-Massri, et al. · European Journal of Pharmacology

2026 · Hana Abbasian, Amir Abdi, et al. · Elsevier eBooks

Linking exosomes and neuropathy in diabetics conditions

2026 · Lamiaa A. Ahmed, Khaled F. Al-Massri · Elsevier eBooks

Gut Microbiota Modulation in CNS Disorders: Therapeutic Strategies and Implications for Drug Efficacy

2026 · Lamiaa A. Ahmed, Khaled F. Al-Massri · Molecular Neurobiology

Therapeutic Efficacy of Mesenchymal Stem Cells and Their Derived Exosomes in Different Neurodegenerative Disorders

2025 · Lamiaa A Ahmed, Khaled F Al-Massri, et al. · CRC Press eBooks

Works count: 15

Citation count: 256

H-index: 7

I10-index: 7